Cargando…
Early-onset Cardiotoxicity assessment related to anthracycline in children with leukemia. A Prospective Study
BACKGROUND: Acute leukemias are the most frequent malignancies in children. Advances in treatment have improved the overall survival to 80%. Almost 10% of children with cancer develop clinical cardiac toxicity. Total anthracycline cumulative dose is a risk factor for early-onset cardiotoxicity. OBJE...
Autores principales: | Linares Ballesteros, Adriana, Sanguino Lobo, Roy, Villada Valencia, Juan Camilo, Arévalo Leal, Oscar, Plazas Hernández, Diana Constanza, Aponte Barrios, Nelson, Perdomo Ramírez, Iván |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Universidad del Valle
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8054707/ https://www.ncbi.nlm.nih.gov/pubmed/33911320 http://dx.doi.org/10.25100/cm.v52i1.4542 |
Ejemplares similares
-
Cardiotoxicity of Anthracyclines
por: Cardinale, Daniela, et al.
Publicado: (2020) -
Anthracycline Chemotherapy and Cardiotoxicity
por: McGowan, John V, et al.
Publicado: (2017) -
Coronary microcirculation damage in anthracycline cardiotoxicity
por: Galán-Arriola, Carlos, et al.
Publicado: (2021) -
The role of iron in anthracycline cardiotoxicity
por: Gammella, Elena, et al.
Publicado: (2014) -
Updates in Anthracycline-Mediated Cardiotoxicity
por: Nebigil, Canan G., et al.
Publicado: (2018)